Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 1 | +100K | 93.3% | $0.49 | +$49.4K |
Sells | 1 | -7.13K | 6.7% | $0.61 | -$4.35K |
Net | 0 | +92.9K | 86.7% | +$45K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
IVor Royston | Director | $665K | Aug 25, 2024 | ||
Roger Pomerantz | Director | $106K | Aug 25, 2024 | ||
Daniel R. Chevallard | CFO and COO | $91.9K | -$4.35K | -4.52% | Mar 12, 2024 |
Lisa Rojkjaer | Chief Medical Officer | $77.6K | Mar 16, 2023 | ||
Mark Rothera | President and CEO, Director | $49.3K | +$49.4K | Mar 12, 2024 | |
Flavia Borellini | Director | Jun 20, 2024 | |||
Stephen Rubino | Director | Jun 20, 2024 | |||
Jane F. Barlow | Director | Jun 20, 2024 | |||
Thomas E. Darcy | Director | Jun 20, 2024 | |||
Michael Huang | Director | Jun 9, 2022 | |||
Samuel Lafayette Murphy | Director | Jun 20, 2024 | |||
Nicole Onetto | Director | Jun 9, 2022 | |||
Darrel P. Cohen | Chief Medical Officer | Mar 12, 2024 | |||
Melody Burcar | Senior VP, Finance | Mar 20, 2024 | |||
Barry J. Simon | Director | Jun 20, 2024 | |||
Jane Chung | Director | Jun 20, 2024 | |||
Michael E. Faerm | Chief Financial Officer | May 14, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|